Kiniksa Pharmaceuticals International (KNSA) Deferred Taxes (2017 - 2026)
Kiniksa Pharmaceuticals International's (KNSA) quarterly Deferred Taxes came in at $2.7 million in Q2 2026, up 0.64% YoY from $2.6 million in Q2 2025, and down 41.17% on a QoQ basis from $4.5 million in Q1 2026.
Kiniksa Pharmaceuticals International (KNSA) Deferred Taxes (2017 - 2026) Analysis & Trends
Kiniksa Pharmaceuticals International (KNSA) has 10 years of Deferred Taxes data on file, last reported at $2.7 million in Q2 2026.
- Quarterly Deferred Taxes rose 0.64% year-over-year to $2.7 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $17.5 million (up 560.45% YoY) and the FY2025 annual result came in at $15.9 million, up 33.33% from the prior year.
- Deferred Taxes eased to $2.7 million in Q2 2026, from $4.5 million in the prior quarter.
- In the past five years, Deferred Taxes ranged from a high of $10.6 million in Q2 2024 to a low of -$25.7 million in Q4 2023.
- A 5-year average of $107200.0 and a median of $2.7 million in 2026 frame the typical range for Deferred Taxes.
- Annual changes were most pronounced in 2023 — Deferred Taxes plunged 7487.64% — and 2025, when it soared 836.32%.
- Tracing KNSA's Deferred Taxes over 5 years: stood at $348000.0 in 2022, then sank by 7487.64% to -$25.7 million in 2023, then jumped by 102.52% to $647000.0 in 2024, then soared by 836.32% to $6.1 million in 2025, then sank by 56.07% to $2.7 million in 2026.
- The last three Deferred Taxes figures came in at $2.7 million (Q2 2026), $4.5 million (Q1 2026), and $6.1 million (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 25.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -33.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 25.70 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -124.50 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | -25.30 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Kiniksa Pharmaceuticals International | 6.09 Bn | 5.57 Bn | 220.03 Mn | 2.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.66 Mn |
| Mar 31, 2026 | 4.52 Mn |
| Dec 31, 2025 | 6.06 Mn |
| Sep 30, 2025 | 4.23 Mn |
| Jun 30, 2025 | 2.64 Mn |
| Mar 31, 2025 | 2.99 Mn |
| Dec 31, 2024 | 647,000.00 |
| Sep 30, 2024 | -3.64 Mn |
| Jun 30, 2024 | 10.57 Mn |
| Mar 31, 2024 | 4.37 Mn |
| Dec 31, 2023 | -25.71 Mn |
| Sep 30, 2023 | 10.29 Mn |
| Jun 30, 2023 | -19.44 Mn |
| Mar 31, 2023 | 1.08 Mn |
| Dec 31, 2022 | 348,000.00 |
| Mar 31, 2021 | 10,000.00 |
| Dec 31, 2020 | 40,000.00 |
| Sep 30, 2020 | -51,000.00 |
| Jun 30, 2020 | 5.41 Mn |
| Mar 31, 2020 | -1.04 Mn |